EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Cluster‐Randomised Controlled Trial of At‐Home Virtual Reality for People With Chronic Musculoskeletal Pain on the Waiting List

Syl Slatman iD, Lieke Heesink, Reinoud Achterkamp, José Broeks, Bram Lemans, Nelson Monteiro de Oliveira, Leonie Brinckate-Oolbekkink, Diede Paarlberg, Heleen Reinders-Messelink, Remko Ter Riet, Marjolein Stegeman, Jesper Knoop und 1 weitere

European Journal of Pain · 2025-07 · 29 (6)

DOI: 10.1002/ejp.70073 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pain, online erschienen am 05.07.2025. Verfasst von Syl Slatman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Signals and Systems Group, Faculty of Electrical Engineering, Mathematics and Computer Science, University of Twente, Enschede, the Nether…. Hauptthemen laut MEDLINE: Musculoskeletal Pain, Chronic Pain, Virtual Reality, Pain Management. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Virtual reality (VR) has been introduced as a novel intervention in chronic musculoskeletal pain (CMP) rehabilitation. However, much remains unknown about the effectiveness of VR for CMP. The aim of this study was to examine the effectiveness of VR in daily life versus no treatment for people with CMP who were on a waiting list to receive secondary pain treatment.

Methods

This study employed a cluster‐randomised, controlled design. The intervention group received a novel VR application that offers pain education and pain management techniques. This home‐based, stand‐alone, immersive VR intervention was advised to be used daily for four weeks. The control group received no treatment. Primary outcome measure was health‐related quality of life at four weeks; secondary outcome measures included various pain‐related variables (e.g., pain self‐efficacy). Intervention effectiveness was analysed using linear mixed models.

Results

Fifty‐three participants were included in this trial (mean age: 55.5 (SD: 15)) of which 70% were women. No significant between‐group differences were found at four weeks on physical (mean difference (95% CI): 0.039 (−2.810 to 2.889), p = 0.978) or mental (3.590 (−1.640 to 8.819), p = 0.172) health‐related quality of life or any of the secondary outcome measures.

Discussion

The pain education VR intervention showed no effect in improving outcomes for people with CMP who were on a waiting list, compared to a no‐intervention control group. Future research should investigate for which patients, settings, and timing this VR intervention could be beneficial. Significance Statement Prior research showed that VR could be beneficial for people with CMP. However, the results of this study showed that VR is ineffective as stand‐alone therapy for people with CMP who were on a waiting list to receive secondary pain treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Musculoskeletal PainChronic PainVirtual RealityPain ManagementVirtual Reality Exposure TherapyHumansFemaleMaleMiddle AgedWaiting ListsQuality of LifeAdultAgedTreatment OutcomePain Measurement

Stichwörter der Autor:innen

RCTchronic musculoskeletal pain (CMP)eHealthvirtual reality (VR)

Autor:innen und Institutionen

  • Biomedical Signals and Systems Group, Faculty of Electrical Engineering, Mathematics and Computer Science, University of Twente, Enschede, the Netherlands.
  • Musculoskeletal Rehabilitation Research Group, School for Allied Health, HAN University of Applied Sciences, Nijmegen, the Netherlands.
  • Health Technology and Services Research, Faculty of Behavioural, Management and Social Sciences, University of Twente, Enschede, the Netherlands.
  • Department of Chronic Pain, Roessingh Rehabilitation Center, Enschede, the Netherlands.
  • Department of Rehabilitation, Ziekenhuisgroep Twente, Almelo, the Netherlands.
  • Nocepta, Ziekenhuisgroep Twente, Hengelo, the Netherlands.

ORCID-Profile: Syl Slatman

Zitieren

APA

Slatman, S., Heesink, L., Achterkamp, R., Broeks, J., Lemans, B., de Oliveira, N. M., Brinckate-Oolbekkink, L., Paarlberg, D., Reinders-Messelink, H., Ter Riet, R., Stegeman, M., Knoop, J., & Tabak, M. (2025). Cluster‐Randomised Controlled Trial of At‐Home Virtual Reality for People With Chronic Musculoskeletal Pain on the Waiting List. European Journal of Pain, 29(6). https://doi.org/10.1002/ejp.70073

Vancouver

Slatman S, Heesink L, Achterkamp R, Broeks J, Lemans B, de Oliveira NM, et al. Cluster‐Randomised Controlled Trial of At‐Home Virtual Reality for People With Chronic Musculoskeletal Pain on the Waiting List. European Journal of Pain. 2025;29(6). doi:10.1002/ejp.70073

BibTeX
@article{Slatman2025,
  author = {Slatman, Syl and Heesink, Lieke and Achterkamp, Reinoud and Broeks, José and Lemans, Bram and de Oliveira, Nelson Monteiro and Brinckate-Oolbekkink, Leonie and Paarlberg, Diede and Reinders-Messelink, Heleen and Ter Riet, Remko and Stegeman, Marjolein and Knoop, Jesper and Tabak, Monique},
  title = {Cluster‐Randomised Controlled Trial of At‐Home Virtual Reality for People With Chronic Musculoskeletal Pain on the Waiting List},
  journal = {European Journal of Pain},
  year = {2025},
  volume = {29},
  number = {6},
  doi = {10.1002/ejp.70073}
}
Kostenlos starten →